For the Inventor, By the Inventor

Enter assignee name

Morgantown, WV, United States of America

Blanchette Rockefeller Neurosciences Institute

USPTO Granted Patents = 21

CIPO Patents = 9

EPO Patents = 19

Forward Citations = 75

Loading Chart...

Loading Chart...

9 inventors (with patents filed for the assignee):

Daniel L Alkon (21 out of 58 patents)

Thomas J Nelson (5 out of 52 patents)

Tapan Kumar Khan (4 out of 6 patents)

4. Alessandro Quattrone (3 out of 6 patents)

5. Miao-Kun Sun (2 out of 5 patents)

6. Rene Etcheberrigaray (2 out of 6 patents)

7. Wei-Qin Zhao (2 out of 3 patents)

8. Thomas E Nelson (2 out of 57 patents)

9. Florin Valentin Chirila (1 out of 5 patents)

10. Ofer Zohar (1 patent)

11. Jarin Hongpaisan (0 patent)

12. David L Alkon (0 patent)

21 patents: Sort by Forward Citations

1. 9833435 - Compositions and methods to treat Niemann-Pick disease (2017-12-05),

2. 9797913 - Alzheimer's disease-specific alterations of the ERK1/ERK2 phosphorylation ratio-alzheimer's disease-specific molecular biomarkers (ADSMB) (2017-10-24),

3. 9446020 - Methods for Alzheimer'S disease treatment and cognitive enhancement (2016-09-20),

4. 9345685 - Methods for Alzheimer's Disease treatment and cognitive enhancement (2016-05-24),

5. 9188595 - Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation (2015-11-17),

6. 9163032 - Esters of DCPLA and methods of treatment using the same (2015-10-20),

7. 9119825 - PKC-activating compounds for the treatment of neurodegenerative diseases (2015-09-01),

8. 9107890 - PKC activators and anticoagulant in regimen for treating stroke (2015-08-18),

9. 9066923 - Methods for Alzheimer's disease treatment and cognitive enhancement (2015-06-30),

10. 8822166 - Stimulus-elicited genomic profile markers of alzheimer's disease (2014-09-02),

11. 8703812 - Protein synthesis required for long-term memory is induced by PKC activation on days preceding associative learning (2014-04-22),

12. 8658134 - Fibroblast growth patterns for diagnosis of Alzheimer's disease (2014-02-25),

13. 8163800 - PKC-activating compounds for the treatment of neurodegenerative diseases (2012-04-24),

14. 7977377 - Treatment of depressive disorders (2011-07-12),

15. 7803400 - Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier (2010-09-28),

The Blanchette Rockefeller Neurosciences Institute (BRNI) is a non-profit research organization dedicated to understanding the causes of neurodegenerative diseases and developing effective treatments. Through collaboration and advanced scientific research, BRNI aims to accelerate the development of innovative therapies and improve the lives of millions affected by neurological disorders.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

21 Patents

#3 in Morgantown, WV

#22 in West Virginia

#15,181 in US

#29,078 in the World

Morgantown, WV, United States of America

Blanchette Rockefeller Neurosciences Institute

Forward Citations = 75

9 inventors:

Daniel L Alkon (21 out of 58 patents)

Thomas J Nelson (5 out of 52 patents)

Tapan Kumar Khan (4 out of 6 patents)

4. Alessandro Quattrone (3 out of 6 patents)

5. Miao-Kun Sun (2 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…